GlassScriptPhysician profile
Michael S Fleischman
NPI 1275762676
$7,300.46
in general payments reported to CMS, 2019-2025
17 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502 · 2020: $24.15 · 2021: $34.04 · 2022: $2,481 · 2023: $101 · 2024: $2,061 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,663 · Food and Beverage: $1,596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,663.06 |
| Food and Beverage | $1,596.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,422.90 | 2022 | |
| Stryker Corporation | $1,965.68 | 2019-2025 | Mako, Triathlon, Gmrs |
| Zimmer Biomet Holdings, INC. | $1,497.80 | 2024 | Avenir, Tapestry |
| Optimotion Implants, LLC | $436.97 | 2025 | Optimotion Implants |
| Encore Medical, LP | $297.43 | 2019-2025 | Djo Surgical |
| Globus Medical, INC. | $211.03 | 2024 | Distal Femur Plate System |
| Microport Orthopedics INC | $114.50 | 2024 | Mpo Medial Pivot Knee |
| Depuy Synthes Sales INC. | $85.23 | 2019-2025 | Monovisc, Peak, Orthovisc |
| Bioventus LLC | $80.34 | 2019-2025 | Xcell, Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $68.30 | 2023-2024 | Zynrelef |
| Ferring Pharmaceuticals INC. | $29.67 | 2019-2023 | Euflexxa |
| Nalu Medical, INC. | $20.06 | 2023 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $15.59 | 2022 | |
| Abbvie INC. | $15.53 | 2022 | |
| Boston Scientific Corporation | $13.78 | 2023 | Wavewriter Alpha Prime 16 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $13.19 | 2024 | |
| Pacira Therapeutics, INC. | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Fleischman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.